Rotigotine

Rotigotine is a dopamine agonist used for Parkinson's disease and restless leg syndrome (RLS) which is available only as a slow-release transdermal patch applied to the skin. Rotigotine is also sold under the brand name Neupro. Rotigotine is in the same class of drugs as ropinirole and pramipexole.

Evidence
No clinicial trials have yet been carried out of rotigotine for patients with ME/CFS.

A single study of rotigotine for fibromyalgia had high dropout rates for both the drug and placebo, but did not appear to show a significant improvement in pain or other fibromyalgia symptoms at doses of 4mg or 8mg.

There is inconsistent evidence of the effect of rotigotine on fatigue in Parkinson's disease.

Clinicians

 * Olli Polo

Notable studies

 * 2007, The use of rotigotine for treatment of reducing signs and symptoms of fibromyalgia in adults. Summary (not peer reviewed)

Learn more

 * Rotigotine - drugs.com
 * Rotigotine transdermal - drugs.com
 * Rotigotine - MedlinePlus
 * Rotigotine - DrugBank Online